Study Finds Semaglutide May Slow Biological Aging

A recent study revealed that semaglutide, the active ingredient in the popular weight-loss drugs Ozempic and Wegovy, may slow biological aging. The research focused on adults with HIV and found that semaglutide slowed biological aging markers. This is the first clinical evidence that the drug may have an impact on human aging. The study's findings are encouraging, but scientists emphasize that larger studies are necessary to determine if the medication can indeed help people age more slowly. The researchers are cautious about drawing conclusions, as the current study was limited to adults with HIV. Further research will be needed to fully understand the potential effects of semaglutide on biological aging. The discovery has sparked interest in the potential for semaglutide to be used in aging research. As the study's results are preliminary, more work is required to confirm the findings and explore the possibilities. The medical community awaits the results of future studies to determine the potential of semaglutide in slowing biological aging. The current study's results are a promising start, but only time and further research will tell if semaglutide can truly help people age more slowly.